KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insulet (PODD) Change in Accured Expenses (2016 - 2026)

Insulet filings provide 16 years of Change in Accured Expenses readings, the most recent being $161.3 million for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses rose 206.65% to $161.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $161.2 million, a 201.87% increase, with the full-year FY2025 number at $161.2 million, up 201.87% from a year prior.
  • Change in Accured Expenses hit $161.3 million in Q4 2025 for Insulet, up from -$19.8 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $161.3 million in Q4 2025 to a low of -$35.9 million in Q1 2023.
  • Median Change in Accured Expenses over the past 5 years was $1.0 million (2022), compared with a mean of $11.9 million.
  • The widest YoY moves for Change in Accured Expenses: up 16200.0% in 2023, down 1136.84% in 2023.
  • Insulet's Change in Accured Expenses stood at $28.3 million in 2021, then tumbled by 93.29% to $1.9 million in 2022, then tumbled by 1136.84% to -$19.7 million in 2023, then soared by 367.01% to $52.6 million in 2024, then surged by 206.65% to $161.3 million in 2025.
  • The last three reported values for Change in Accured Expenses were $161.3 million (Q4 2025), -$19.8 million (Q3 2025), and $19.6 million (Q2 2025) per Business Quant data.